Patent · US Active

Methods and apparatus for creating particle derivatives of HDL with reduced lipid content

US8637460B2 · kind B2 · utility

5Cited by
126References
24Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 31, 2012
Grant dateJan 28, 2014
Priority date
Expiry dateAug 31, 2032

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N33/92
  • WIPO fieldChemical engineering
  • WIPO sectorChemistry

Abstract

The present invention is directed to systems, apparatus and methods for creating derivatives of at least one form of HDL without substantially affecting LDL. These derivatives of HDL are particles with reduced lipid content, particularly reduced cholesterol content. These particles have the capacity to bind cholesterol and are administered to a patient to enhance cellular cholesterol efflux and reduce cholesterol levels in cells, tissues, organs, and blood vessels. The present method is useful for treating atherogenic vascular disease and may be combined with other therapies such as statins, inhibitors of cholesterol absorption, niacin, anti-inflammatories, exercise and dietary restriction.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.